INTERNATIONAL MYELOMA SOCIETY
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$10,780,552
Cash & Equivalents
89%
Other Assets
11%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$95,383
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$7,169,047
$9,591,576
+34%
Receivables (Non-Related)
$0
$0
-
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$0
$0
-
Investments
$0
$0
-
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
$1,624,533
$1,188,976
-27%
Total Assets
$8,793,580
$10,780,552
+23%
Liabilities
2023
2024
Change
Payables & Accruals
-
$95,383
-
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$79,414
-
-
Total Liabilities
$79,414
$95,383
+20%
Net assets
2023
2024
Change
Restricted Net Assets
-
$4,040,260
-
Unrestricted Net Assets
-
$6,644,909
-
Net assets
2023
2024
Change
Net assets
+$8,714,166
+$10,685,169
+23%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)